Medineutrina Private Limited
About Medineutrina Private Limited
Data last updated:
Medineutrina Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 August 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Nagpur, under CIN U51900MH2014PTC256947.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Shila Manendra Kshirsagar and Dilipkumar Gulabchand Bora.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 20 Near Kdk College Shree Nagar Nandanwan, Nagpur, Maharashtra, India – 440009.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.01 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹5.4 Lakh (net margin -89.9%) and EBITDA of ₹5.07 Lakh (EBITDA margin 84.5%).
As per MCA filings, the company has open charges of ₹70 Lakh on record. Court records list 3 cases involving the company, including 2 filed by the company and 1 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Medineutrina Private Limited's registered office is in Nagpur, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No. 20 Near Kdk College Shree Nagar Nandanwan, Nagpur, Maharashtra, India – 440009
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Medineutrina Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Medineutrina Private Limited
FY 2025 filings availableMedineutrina Private Limited reported revenue of ₹6.01 Lakh (up 300% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 300% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.07 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹5.4 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 84.5% | ||||
| Net Profit Margin | -89.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medineutrina Private Limited, buy the company report.
Board of directors of Medineutrina Private Limited
Medineutrina has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shila Manendra Kshirsagar Also directs: Flo Equipment Private Limited | Director | 28 Apr 2021 | 5 Years 6 Months | Current |
| Dilipkumar Gulabchand Bora | Director | 01 Oct 2015 | 11 Years 1 Months | Current |
Peer comparison
Medineutrina Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medilexicon Pharmaceuticals Private Limited | ₹6.09 Lakh (FY 2024) | 23.0% | Jaipur, Rajasthan, India | |||
| Nobel Enkem Private Limited | ₹6.08 Lakh (FY 2024) | 3.0% | Patna, Bihar, India | |||
| 1St Rate Pharma Private Limited | ₹6.05 Lakh (FY 2025) | Thane, Maharashtra, India | ||||
| Current Formulations Private Limited | ₹6.03 Lakh (FY 2024) | -2.0% | Thattachavadi, Puducherry, India | |||
| Turquoise House of Design and Trading Private Limited | ₹6.02 Lakh (FY 2024) | -2.0% | Haryana, India | |||
| Medineutrina Private Limitedthis company | ₹6.01 Lakh (FY 2025) | -₹5.4 Lakh | -89.9% | 300.0% | Nagpur, Maharashtra, India | |
| Marpu Builders Limited | ₹6 Lakh (FY 2024) | Secunderabad, Telangana, India | ||||
| Medifirst Pharma Private Limited | ₹5.99 Lakh (FY 2021) | Nashik, Maharashtra, India | ||||
| Mahi Biotech Limited | ₹5.95 Lakh (FY 2025) | -67.0% | Budaun, Uttar Pradesh, India | |||
| Lucida Pharmaceuticals Private Limited | ₹5.9 Lakh (FY 2025) | -33.0% | Aurangabad, Maharashtra, India | |||
| Vision Pharmatech Exports Private Limited | ₹5.88 Lakh (FY 2025) | 76.0% | Bangalore, Karnataka, India |
To see the full peer comparison of Medineutrina Private Limited, buy the company report.
Auditor
Medineutrina Private Limited is audited by SARDA SONI ASSOCIATES LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SARDA SONI ASSOCIATES LLP | FY 2023 | 117235W/W100126 |
Shareholding
The shareholding of Medineutrina Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Medineutrina Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Mar 2017 | 100094477 | Others | ₹50 Lakh | Open | |
| 29 Mar 2017 | 100094480 | Others | ₹20 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
Medineutrina Private Limited has 3 court cases on record: 2 filed by Medineutrina, 1 filed against it. 1 case is pending and 2 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| Supreme Court | 2 | 1 | 1 |
| High courts | 1 | 0 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Supreme Court | Court case (0602-Banking : Securitization and Reconstruction of Financial Assets and Enforcement of Security Interest Act, 2002, debt recovery by banks, financial institutions, cooperative banks and negotiable instruments [other than criminal prosecution]) | Filed against the company by Kotak Mahindra Bank Limited Through Authorised Representative 6 Th Floor, 12-Bkc, Plot No. C-12, G Block, Bandra Kurla Complex, Bandra (East) ,Mumbai , Maharashtra | Pending |
| Supreme Court | Court case (1807-Ordinary Civil Matters : Others) | Filed by the company against District Industries Centre (D.I.C.) Udyog Bhavan ,Nagpur , Maharashtra and 2 others | Disposed |
| Bombay High Court | Writ petition | Filed by the company against District Industries Centre (D.I.C.) Nagpur and Others | Disposed |
To see the full case history of Medineutrina Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medineutrina Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Medineutrina Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Medineutrina Private Limited has 8 board changes on record since 2015: 2 appointments and 6 cessations. The latest: Shila Manendra Kshirsagar ceased to be Additional Director on 30 Nov 2021.
1 earlier event is in the company report.
Frequently asked questions
Medineutrina is an active private limited company based in Nagpur, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 06 August 2014 (12+ years old) and is registered under CIN U51900MH2014PTC256947.
Medineutrina has 2 current directors:
- Shila Manendra Kshirsagar - Director
- Dilipkumar Gulabchand Bora - Director
The latest financial statements of Medineutrina on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Medineutrina is U51900MH2014PTC256947. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medineutrina has 3 court cases on record: 2 filed by the company and 1 filed against it. 1 is pending. Most are in the supreme court.
Medineutrina was incorporated on 06 August 2014, making it 12+ years old. It is registered with the Registrar of Companies, Nagpur.
The peers of Medineutrina by revenue are Medilexicon Pharmaceuticals Private Limited, Nobel Enkem Private Limited, 1St Rate Pharma Private Limited, Current Formulations Private Limited, Turquoise House of Design and Trading Private Limited and 5 more, all in the Pharma industry (Formulations).
Shila Manendra Kshirsagar ceased to be Additional Director on 30 Nov 2021. Aditya Kshirsagar Mahendra ceased to be Director on 29 Apr 2021. Shila Manendra Kshirsagar was appointed as Director on 28 Apr 2021. Medineutrina has 8 board changes on record in total.
The registered office of Medineutrina is at Plot No. 20 Near Kdk College Shree Nagar Nandanwan, Nagpur, Maharashtra, India – 440009.
Medineutrina operates in the pharma industry, in the drug formulation and development segment.
Medineutrina has open charges of ₹70 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
